PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
South Florida Institute for Reproductive...

Press Release


Receive press releases from South Florida Institute for Reproductive Medicine: By Email RSS Feeds:

New Natural Treatment for Polycystic Ovarian Syndrome Rivals Prescription Medicines Without Side Effects


Novel Alternative Treatment Option Now Available to Millions of American Women with Hormone Imbalance and Infertility.

Jupiter, FL, May 09, 2012 --(PR.com)-- A natural supplement previously exclusively available in Europe has been released in U.S. pharmacies to help millions of women diagnosed with Polycystic Ovarian Syndrome (PCOS). Scott Roseff, MD, FACOG, of the South Florida Institute for Reproductive Medicine (SFIRM), is a renowned fertility specialist and expert in the diagnosis and treatment of PCOS. Dr. Roseff investigated Pregnitude (Everett Labs, NJ), an all-natural supplement designed to address the deficiencies found in the ovaries of women plagued by PCOS.

Astoundingly, Roseff found this therapy improved insulin resistance with the same efficacy as prescription-only metformin but without metformin’s high incidence of side effects. Women with fertility challenges ovulated on over-the-counter Pregnitude as frequently as patients taking prescription Clomid (clomiphene citrate) but were free of the multitude of adverse reactions and risks commonly known with Clomid. Many patients undergoing in-vitro fertilization (IVF) were found to have better quality eggs and embryos after taking Pregnitude. Dr. Roseff was invited to Rome in 2011 as a plenary speaker to present his data to the Italian Ob-Gyn Societies and his findings were well received.

Approximately 10% of women between the ages of 14 and 40 have PCOS, a devastating combination of hormone imbalances that can lead to severe medical and reproductive repercussions including hypertension, obesity, hyperlipidemia, heart disease, insulin resistance, type II diabetes, breast cancer, uterine cancer, irregular menstrual cycles, acne, increased male-type facial/body hair growth, difficulty conceiving, an increased risk of miscarriages, and pregnancy complications such as hypertension and gestational diabetes. Dr. Roseff said, “My findings can benefit women diagnosed with PCOS as well as those suffering from various types of infertility. This translates to millions of women in the U.S. and I’m thrilled we now have an all-natural and effective alternative therapy in our armamentarium.” Pregnitude combines myo-inositol and folic acid and became available in U.S. pharmacies this month without a prescription.
Contact Information
South Florida Institute for Reproductive Medicine
Scott Roseff, MD
561-972-6900
Contact
http://www.IVFMD.com

Click here to view the list of recent Press Releases from South Florida Institute for Reproductive Medicine
Promote Your Business